BMS-453 and SCH28080: Difference between pages

Revision as of 08:44, 2 August 2016

"SCH-28080 is a potent inhibitor of gastric H+ and K+-ATPase.."

>104 Xenbase articles contain a reference to SU5402 according to textpresso

@@ Line 1: / Line 1: @@
 ==Description==
-Synthetic retinoid. Retinoic acid receptor β (RARβ) agonist in vivo; RARα and RARγ antagonist in vitro. Inhibits breast cell proliferation by inducing active transforming growth factor β (TGFβ) and causes G1 arrest.
+"SCH-28080 is a potent inhibitor of gastric H+ and K+-ATPase.."
-[[File:bms 453.structure.png|frame|right|Bms 453 structure, image from NCBI Pubchem]]
+*-Sigma product description
-==Alternative Name==
+[[File:Sch-28080.structure.png|frame|right|SCH-28080 structure, image from Pubchem]]
-BMS 189453
-==Chemical Name==
+==Genes Affected==
--[(1E)-2-(5,6-Dihydro-5,5-dimethyl-8-phenyl-2-naphthalenyl)ethenyl]-benzoic acid
 ==Suppliers==
-[https://www.tocris.com/dispprod.php?ItemId=222005#.V2xIRfkrKM8 Tocris]
+==Usage Notes==
 ==References==
-*[http://www.xenbase.org/literature/article.do?method=display&articleId=51800| ''Using frogs faces to dissect the mechanisms underlying human orofacial defects''. Dickinson AJ. Semin Cell Dev Biol. March 1, 2016; 51 54-63.]
+*[https://pubchem.ncbi.nlm.nih.gov/compound/Sch-28080 PubChem]
-*National Center for Biotechnology Information. PubChem Compound Database; CID=9875424, [http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=9875424]
+>104 Xenbase articles contain a reference to SU5402 according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso]
+*
+*[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]]